ProducsDistribution Products

OPTIVATE 1000

Therapeutic indication:

Treatment and prophylaxis of bleeding with hemophilia A (congenital factor VIII deficiency).

  • Composition: Factor VIII 1000 IU/vial, Von willebrand factor 2600 IU/vial
  • Pharmaceutical form: Powder for solution for injection
  • Method of administration: Intravenous
  • Manufacturer: Bio Products Laboratory Limited (BPL)